This is the authors' abstract. We don't add key points for this paper.
Larynx preservation without jeopardizing survival appears feasible in patients with cancer of the hypopharynx. On the basis of these observations, the EORTC has now accepted the use of induction chemotherapy followed by radiation as the new standard treatment in its future phase III larynx preservation trials.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lefebvre et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: